| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $186.7M | — | +198.7% |
| R&D Expense | $5.6M | — | +513.5% |
| SG&A Expense | $50.7M | — | +214.1% |
| Operating Income | -$39.2M | — | -289.0% |
| Pre-tax Income | -$52.5M | — | -5487.3% |
| Income Tax | $2K | — | — |
| Net Income | -$37.4M | — | -228.1% |
| EPS (Basic) | -$0.25 | — | -127.3% |
| EPS (Diluted) | -$0.25 | — | -127.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $231.6M | -60.2% | -37.9% |
| Accounts Receivable | $105.8M | +767.6% | +260.5% |
| Inventory | $57.9M | — | — |
| Current Assets | $505.3M | -18.3% | +17.1% |
| Total Assets | $1.72B | +126.9% | +243.6% |
| Current Liabilities | $415.5M | +232.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$54.8M | — | -382.0% |
| Capital Expenditures | $9.9M | — | +61.3% |
| Investing Cash Flow | -$454.7M | — | -7326.6% |
| Financing Cash Flow | $167.4M | — | +9.9% |
| Free Cash Flow | -$64.6M | — | -586.2% |
| +323.3% |
| Long-term Debt | $335.8M | +0.2% | — |
| Total Liabilities | $986.8M | +78.3% | +472.4% |
| Stockholders' Equity | -$334.3M | +55.7% | -144.2% |